Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bisoprolol
2. Bisoprolol Fumarate (1:1) Salt, (+-)-isomer
3. Bisoprolol Fumarate (2:1) Salt, (+-)-isomer
4. Bisoprolol Hydrochloride
5. Bisoprolol Methanesulfonate Salt
6. Bisoprolol, (+-)-isomer
7. Bisoprolol, (-)-isomer
8. Bisoprolol, Fumarate (1:1) Salt
9. Bisoprolol, Fumarate (2:1) Salt
10. Cl 297939
11. Cl-297939
12. Cl297939
13. Concor
14. Emd 33512
15. Emd-33512
16. Emd33512
17. Fumarate, Bisoprolol
18. Hydrochloride, Bisoprolol
1. 104344-23-2
2. Zebeta
3. Bisoprolol Hemifumarate
4. Bisoprolol Monofumarate
5. Fondril
6. Maintate
7. Concor
8. 105878-43-1
9. Bisoprolol (fumarate)
10. Bisoprolol Hemifumarate Salt
11. U057cx04h0
12. Emd33512
13. Ta-4708
14. Cl-297939
15. 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol,(2e)-2-monobutenedioate
16. 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (2e)-2-butenedioate (1:1)
17. 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (2e)-2-butenedioate (1:1) (salt)
18. 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (e)-2-butenedioate (1:1) (salt)
19. Smr000471619
20. Emd-33512
21. Bisocard
22. Cardicor
23. Congescor
24. Sr-01000597980
25. Bisoprololfumarate
26. Concor Cor
27. 66722-45-0
28. Bisoprolol Fumarate (1:x)
29. Schembl41419
30. Mls001076669
31. Mls001401436
32. Unii-u057cx04h0
33. Chembl1200708
34. Bcpp000331
35. Hms1569a21
36. Hms2051i16
37. Hms2094o19
38. Hms2233f12
39. Hms3884o05
40. Pharmakon1600-01505704
41. Nsc759181
42. S1206
43. Akos005267174
44. Ac-5016
45. Bcp9000419
46. Ccg-100883
47. Ccg-213520
48. Nc00133
49. Nsc-759181
50. Hy-120829
51. B3994
52. Cs-0079270
53. Sw197151-3
54. 104b232
55. Q-200729
56. Sr-01000597980-4
57. Q27290514
58. 1-(4-((2-isopropoxyethoxy)methyl)phenoxy)-3-(isopropylamino)propan-2-ol Hemi-fumarate
59. 1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)-2-propanol Fumaric Acid Salt
| Molecular Weight | 441.5 g/mol |
|---|---|
| Molecular Formula | C22H35NO8 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 14 |
| Exact Mass | 441.23626707 g/mol |
| Monoisotopic Mass | 441.23626707 g/mol |
| Topological Polar Surface Area | 135 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 397 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Bisoprolol fumarate |
| Drug Label | Bisoprolol fumarate is a synthetic, beta1-selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is ()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-butenedioate... |
| Active Ingredient | Bisoprolol fumarate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 5mg; 10mg |
| Market Status | Prescription |
| Company | Teva Pharms; Unichem Pharms (usa); Aurobindo Pharma; Sandoz; Mylan |
| 2 of 4 | |
|---|---|
| Drug Name | Zebeta |
| PubMed Health | Bisoprolol (By mouth) |
| Drug Classes | Antianginal, Antihypertensive, Cardiovascular Agent |
| Drug Label | ZEBETA (bisoprolol fumarate) is a synthetic, beta1-selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is ()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-but... |
| Active Ingredient | Bisoprolol fumarate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 5mg; 10mg |
| Market Status | Prescription |
| Company | Teva Womens |
| 3 of 4 | |
|---|---|
| Drug Name | Bisoprolol fumarate |
| Drug Label | Bisoprolol fumarate is a synthetic, beta1-selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is ()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-butenedioate... |
| Active Ingredient | Bisoprolol fumarate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 5mg; 10mg |
| Market Status | Prescription |
| Company | Teva Pharms; Unichem Pharms (usa); Aurobindo Pharma; Sandoz; Mylan |
| 4 of 4 | |
|---|---|
| Drug Name | Zebeta |
| PubMed Health | Bisoprolol (By mouth) |
| Drug Classes | Antianginal, Antihypertensive, Cardiovascular Agent |
| Drug Label | ZEBETA (bisoprolol fumarate) is a synthetic, beta1-selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is ()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-but... |
| Active Ingredient | Bisoprolol fumarate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 5mg; 10mg |
| Market Status | Prescription |
| Company | Teva Womens |
Adrenergic beta-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 10MG **Federal Registe...DOSAGE - TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 19982
DOSAGE - TABLET;ORAL - 5MG **Federal Register...DOSAGE - TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 19982
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Huzhou Sunflower Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Direct Compression
Thickeners and Stabilizers
Granulation
Solubilizers
Disintegrants & Superdisintegrants
Film Formers & Plasticizers
Topical
Lubricants & Glidants
Taste Masking
Co-Processed Excipients
Emulsifying Agents
Rheology Modifiers
Chewable & Orodispersible Aids
Parenteral
API Stability Enhancers
Empty Capsules
Vegetarian Capsules
Surfactant & Foaming Agents
Coloring Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
65
PharmaCompass offers a list of Bisoprolol Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bisoprolol Fumarate manufacturer or Bisoprolol Fumarate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bisoprolol Fumarate manufacturer or Bisoprolol Fumarate supplier.
PharmaCompass also assists you with knowing the Bisoprolol Fumarate API Price utilized in the formulation of products. Bisoprolol Fumarate API Price is not always fixed or binding as the Bisoprolol Fumarate Price is obtained through a variety of data sources. The Bisoprolol Fumarate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bisocard manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bisocard, including repackagers and relabelers. The FDA regulates Bisocard manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bisocard API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bisocard manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bisocard supplier is an individual or a company that provides Bisocard active pharmaceutical ingredient (API) or Bisocard finished formulations upon request. The Bisocard suppliers may include Bisocard API manufacturers, exporters, distributors and traders.
click here to find a list of Bisocard suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bisocard DMF (Drug Master File) is a document detailing the whole manufacturing process of Bisocard active pharmaceutical ingredient (API) in detail. Different forms of Bisocard DMFs exist exist since differing nations have different regulations, such as Bisocard USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bisocard DMF submitted to regulatory agencies in the US is known as a USDMF. Bisocard USDMF includes data on Bisocard's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bisocard USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bisocard suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bisocard Drug Master File in Japan (Bisocard JDMF) empowers Bisocard API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bisocard JDMF during the approval evaluation for pharmaceutical products. At the time of Bisocard JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bisocard suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bisocard Drug Master File in Korea (Bisocard KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bisocard. The MFDS reviews the Bisocard KDMF as part of the drug registration process and uses the information provided in the Bisocard KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bisocard KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bisocard API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bisocard suppliers with KDMF on PharmaCompass.
A Bisocard CEP of the European Pharmacopoeia monograph is often referred to as a Bisocard Certificate of Suitability (COS). The purpose of a Bisocard CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bisocard EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bisocard to their clients by showing that a Bisocard CEP has been issued for it. The manufacturer submits a Bisocard CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bisocard CEP holder for the record. Additionally, the data presented in the Bisocard CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bisocard DMF.
A Bisocard CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bisocard CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bisocard suppliers with CEP (COS) on PharmaCompass.
A Bisocard written confirmation (Bisocard WC) is an official document issued by a regulatory agency to a Bisocard manufacturer, verifying that the manufacturing facility of a Bisocard active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bisocard APIs or Bisocard finished pharmaceutical products to another nation, regulatory agencies frequently require a Bisocard WC (written confirmation) as part of the regulatory process.
click here to find a list of Bisocard suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bisocard as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bisocard API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bisocard as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bisocard and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bisocard NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bisocard suppliers with NDC on PharmaCompass.
Bisocard Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bisocard GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bisocard GMP manufacturer or Bisocard GMP API supplier for your needs.
A Bisocard CoA (Certificate of Analysis) is a formal document that attests to Bisocard's compliance with Bisocard specifications and serves as a tool for batch-level quality control.
Bisocard CoA mostly includes findings from lab analyses of a specific batch. For each Bisocard CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bisocard may be tested according to a variety of international standards, such as European Pharmacopoeia (Bisocard EP), Bisocard JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bisocard USP).
